Beta100% was sold under disclosed trading plans. The largest seller, Terrance Coyne (EVP & CFO), sold $39.0M.Share-of-stake figures for this company are being verified and will be added when that check is finished. Why
Routine activity: 100% of sales were under disclosed plans, and no insider sold more than 1% of vested holdings.
A share of stake is shown for 0 of the 5 officers and directors who sold. 16 are left out Disclosed company stock is not an insider's whole wealth.i
Left out: Pablo Legorreta, George Lloyd, Terrance Coyne, Christopher Hite, Marshall Urist, Arthur McGivern, Gregory Norden, Henry Fernandez, Errol Desouza, Bonnie Bassler, Ted Love, Catherine Engelbert, David Hodgson, Vlad Coric, Carole Ho and Elizabeth Weatherman (share of stake is being verified).
Officers and directors, past 12 months. Their share of stake is being verified and is not shown yet; amounts and trading plans are below.
Officers and directors, Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
| Who | Shares | Price | % of total stake | Total stake after | Trade date | Filed |
|---|---|---|---|---|---|---|
| Marshall Urist EVP, Research & Investments | 4,126 | $57.10 | n/a | n/a | Oct 5, 2026 | Oct 5, 2026 |
| Who | Shares | Price | % of total stake | Total stake after | Trade date | Filed |
|---|---|---|---|---|---|---|
| Marshall Urist EVP, Research & Investments | 4,126 | $57.88 | n/a | n/a | Sep 28, 2026 | Sep 30, 2026 |
| Who | Shares | Price | % of total stake | Total stake after | Trade date | Filed |
|---|---|---|---|---|---|---|
| Christopher Hite EVP & Chairman, Partnering | 100,000 | $58.53 | n/a | n/a | Sep 22, 2026 | Sep 24, 2026 |
"% of total stake" is the shares in an event against all the vested shares the person held that day, across every share class and holding entity, after that day's vesting. "n/a" means the person's holdings are not confirmed, or the row is a purchase. "Holdings record incomplete" means more shares were sold than the filings show the person held that day, so a percentage would be wrong.
No. Pablo Legorreta reported no open-market sales in the past 12 months.
Filings rarely give a reason, and we don't guess at one. What they show is how the sales were made: 100% of sales by value ran under 10b5-1 trading plans disclosed in the filings. A trading plan schedules sales in advance.
No. Officers and directors reported no purchases in the past 12 months.
| Who sold | Amount | % of holdings | Trading plan |
|---|---|---|---|
| Terrance Coyne EVP & CFO | $39.0M 910K shares | Not confirmedshare of stake is being verified. Why | Disclosed plan |
| Christopher Hite EVP & Chairman, Partnering | $27.4M 480K shares | Not confirmedshare of stake is being verified. Why | Disclosed plan |
| George Lloyd EVP, Investments & CLO | $13.8M 355K shares | Not confirmedshare of stake is being verified. Why | Disclosed plan |
| Marshall Urist EVP, Research & Investments | $12.5M 297K shares | Not confirmedshare of stake is being verified. Why | Disclosed plan |
| Gregory Norden Director | $161K 3K shares | Not confirmedshare of stake is being verified. Why | Disclosed plan |
Vested shares across all share classes, held directly and through trusts, LLCs and family members, as reported on SEC Forms 3, 4 and 5. Unvested awards and options are never counted as owned shares.
| Insider | Held Oct 16, 2025 | Sold | Held Oct 16, 2026 | Still held | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pablo Legorreta!Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for Pablo Legorreta are complete. CEO, Chairman of the Board, Director | n/a | 0 | n/a | n/a | ||||||||
Vesting, gifts, unvested awards and holding lines for Pablo LegorretaHoldings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Pablo Legorreta are complete; balances and unit counts will be added when the check is finished. 0gifted (net of own trusts) Stock options (not counted as shares):
Estimate: options held × ($57.10 − strike price), using the most recent insider trade price on Form 4 (Oct 5, 2026), not a market close. | ||||||||||||
George Lloyd!Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for George Lloyd are complete. EVP, Investments & CLO | n/a | −355K | n/a | n/a | ||||||||
Vesting, gifts, unvested awards and holding lines for George LloydHoldings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for George Lloyd are complete; balances and unit counts will be added when the check is finished. 0gifted (net of own trusts) | ||||||||||||
Terrance Coyne!Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for Terrance Coyne are complete. EVP & CFO | n/a | −910K | n/a | n/a | ||||||||
Vesting, gifts, unvested awards and holding lines for Terrance CoyneHoldings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Terrance Coyne are complete; balances and unit counts will be added when the check is finished. −19Kgifted (net of own trusts) | ||||||||||||
Christopher Hite!Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for Christopher Hite are complete. EVP & Chairman, Partnering | n/a | −480K | n/a | n/a | ||||||||
Vesting, gifts, unvested awards and holding lines for Christopher HiteHoldings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Christopher Hite are complete; balances and unit counts will be added when the check is finished. −17Kgifted (net of own trusts) | ||||||||||||
Marshall Urist!Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for Marshall Urist are complete. EVP, Research & Investments | n/a | −297K | n/a | n/a | ||||||||
Vesting, gifts, unvested awards and holding lines for Marshall UristHoldings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Marshall Urist are complete; balances and unit counts will be added when the check is finished. 0gifted (net of own trusts) | ||||||||||||
Arthur McGivern!Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for Arthur McGivern are complete. EVP, Investments & GC | n/a | 0 | n/a | n/a | ||||||||
Vesting, gifts, unvested awards and holding lines for Arthur McGivernHoldings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Arthur McGivern are complete; balances and unit counts will be added when the check is finished. 0gifted (net of own trusts) | ||||||||||||
Gregory Norden!Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for Gregory Norden are complete. Director | n/a | −3K | n/a | n/a | ||||||||
Vesting, gifts, unvested awards and holding lines for Gregory NordenHoldings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Gregory Norden are complete; balances and unit counts will be added when the check is finished. 0gifted (net of own trusts) | ||||||||||||
Henry Fernandez!Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for Henry Fernandez are complete. Director | n/a | 0 | n/a | n/a | ||||||||
Vesting, gifts, unvested awards and holding lines for Henry FernandezHoldings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Henry Fernandez are complete; balances and unit counts will be added when the check is finished. 0gifted (net of own trusts) | ||||||||||||
Errol Desouza!Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for Errol Desouza are complete. Director | n/a | 0 | n/a | n/a | ||||||||
Vesting, gifts, unvested awards and holding lines for Errol DesouzaHoldings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Errol Desouza are complete; balances and unit counts will be added when the check is finished. 0gifted (net of own trusts) | ||||||||||||
Bonnie Bassler!Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for Bonnie Bassler are complete. Director | n/a | 0 | n/a | n/a | ||||||||
Vesting, gifts, unvested awards and holding lines for Bonnie BasslerHoldings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Bonnie Bassler are complete; balances and unit counts will be added when the check is finished. 0gifted (net of own trusts) | ||||||||||||
Ted Love!Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for Ted Love are complete. Director | n/a | 0 | n/a | n/a | ||||||||
Vesting, gifts, unvested awards and holding lines for Ted LoveHoldings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Ted Love are complete; balances and unit counts will be added when the check is finished. 0gifted (net of own trusts) | ||||||||||||
Catherine Engelbert!Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for Catherine Engelbert are complete. Director | n/a | 0 | n/a | n/a | ||||||||
Vesting, gifts, unvested awards and holding lines for Catherine EngelbertHoldings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Catherine Engelbert are complete; balances and unit counts will be added when the check is finished. 0gifted (net of own trusts) | ||||||||||||
David Hodgson!Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for David Hodgson are complete. Director | n/a | 0 | n/a | n/a | ||||||||
Vesting, gifts, unvested awards and holding lines for David HodgsonHoldings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for David Hodgson are complete; balances and unit counts will be added when the check is finished. 0gifted (net of own trusts) | ||||||||||||
Vlad Coric!Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for Vlad Coric are complete. Director | n/a | 0 | n/a | n/a | ||||||||
Vesting, gifts, unvested awards and holding lines for Vlad CoricHoldings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Vlad Coric are complete; balances and unit counts will be added when the check is finished. 0gifted (net of own trusts) | ||||||||||||
Carole Ho!Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for Carole Ho are complete. Director | n/a | 0 | n/a | n/a | ||||||||
Vesting, gifts, unvested awards and holding lines for Carole HoHoldings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Carole Ho are complete; balances and unit counts will be added when the check is finished. 0gifted (net of own trusts) | ||||||||||||
Elizabeth Weatherman!Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for Elizabeth Weatherman are complete. Director | n/a | 0 | n/a | n/a | ||||||||
Vesting, gifts, unvested awards and holding lines for Elizabeth WeathermanHoldings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Elizabeth Weatherman are complete; balances and unit counts will be added when the check is finished. 0gifted (net of own trusts) | ||||||||||||
Holdings and share of stake for Royalty Pharma plc are being verified, so no balances, unit counts or percentages are shown. Sales, proceeds, plan and tax status, titles and dates come straight from individual filings.
Officer and director open-market sales: $92.8M across 2,045,840 shares. Plan status and stated purpose are separate questions, and a sale can have both.
Gifts the filings describe as charitable. Gifts are not sales and are not included in the sale totals.
| Seller | Shares sold | Proceeds | Under a disclosed plan | Share of total | Sales dates |
|---|---|---|---|---|---|
| Terrance Coyne EVP & CFO | 910K | $39.0M | 100% | 42% | Nov 17, 2025 to Aug 13, 2026 |
| Christopher Hite EVP & Chairman, Partnering | 480K | $27.4M | 100% | 29% | Jun 23, 2026 to Sep 22, 2026 |
| George Lloyd EVP, Investments & CLO | 355K | $13.8M | 100% | 15% | Nov 19, 2025 to Dec 18, 2025 |
| Marshall Urist EVP, Research & Investments | 297K | $12.5M | 100% | 14% | Dec 1, 2025 to Oct 5, 2026 |
| Gregory Norden Director | 3K | $161K | 100% | 0.2% | May 14, 2026 to May 14, 2026 |
| Month | Sale proceeds | Disclosed plan | To cover taxes | No plan disclosed |
|---|---|---|---|---|
| Oct 2025 | $0 | $0 | $0 | $0 |
| Nov 2025 | $10.6M | $10.6M | $0 | $0 |
| Dec 2025 | $19.7M | $19.7M | $0 | $0 |
| Jan 2026 | $9.4M | $9.4M | $0 | $0 |
| Feb 2026 | $11.9M | $11.9M | $0 | $0 |
| Mar 2026 | $3.2M | $3.2M | $0 | $0 |
| Apr 2026 | $3.4M | $3.4M | $0 | $0 |
| May 2026 | $5.1M | $5.1M | $0 | $0 |
| Jun 2026 | $16.0M | $16.0M | $0 | $0 |
| Jul 2026 | $508K | $508K | $0 | $0 |
| Aug 2026 | $6.6M | $6.6M | $0 | $0 |
| Sep 2026 | $6.1M | $6.1M | $0 | $0 |
| Oct 2026 | $236K | $236K | $0 | $0 |
In line with the past 5 years. 5 insiders sold; the average is 3 a year.
| 12 months ending | Shares sold | Insiders who sold | Proceeds |
|---|---|---|---|
| Oct 16, 2026 Latest 12 months | 2.05M | 5 | $92.8M |
| Oct 16, 2025 1 year earlier | 34K | 1 | $1.2M |
| Oct 16, 2024 2 years earlier | 470K | 1 | $13.2M |
| Oct 17, 2023 3 years earlier | 2.65M | 4 | $90.7M |
| Oct 17, 2022 4 years earlier | 1.95M | 5 | $80.5M |
| Oct 17, 2021 5 years earlier | 3.48M | 5 | $150M |
Open-market sales (Form 4 code S) by people who were officers or directors, in split-adjusted shares. Earlier years include people who have since left. A sale that an outside holder also reports (a family trust, a fund) is counted with outside holders in every year. Shares, not dollars, are compared, so a change in the stock price doesn't look like a change in selling. Years the filings don't fully cover are shown but left out of the average.
Holdings and share of stake are being verified. Balances, unit counts and every share-of-stake figure for Royalty Pharma plc are held back until that check is finished. Sales, proceeds, plan and tax status, titles and dates come straight from individual filings and are complete.
External context: we only cite outside events when a documented connection exists. None is shown for this period.
All 338 Forms 3, 4 and 5 on record for Royalty Pharma plc (SEC CIK 1802768), filed from Jun 15, 2020 to Oct 5, 2026; 68 of them were filed in the 12 months this page covers, retrieved from SEC EDGAR on Oct 16, 2026. Prices are the ones reported in each filing, often weighted averages.
Holdings. Each holding line (a share class plus an owner, such as a trust or LLC) carries its last reported balance forward. Entities first reported during the period start at zero, so transfers between an insider's own trusts don't count as selling. Lines not reported for three years or more are listed separately and left out of totals.
Sales. A sale counts as under a 10b5-1 plan if its footnote cites one or the filing's Rule 10b5-1 box is checked, and as tax-related if its footnote cites tax obligations or sell-to-cover. Shares withheld by the company for taxes are listed separately. Sales with neither attribute are labeled "no plan disclosed".
| Name | Last filed | Last reported balance |
|---|---|---|
| Rory Riggs | Feb 22, 2024 | 420,286 shares, last reported balance as of Feb 20, 2024 |
| Mario Giuliani | Jan 3, 2024 | 57,747 shares, last reported balance as of Dec 29, 2023 |
| Mario Giuliani | Jan 3, 2024 | 53,923,762 shares, last reported balance as of Dec 29, 2023 |
| James Reddoch | Sep 30, 2022 | 845,830 shares, last reported balance as of Sep 28, 2022 |
| William Ford | Jun 30, 2021 | 2,586,134 shares, last reported balance as of Jun 30, 2021 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | Dec 18, 2020 | 38,714,280 shares, last reported balance as of Dec 18, 2020 |
| Royalty Pharma plc | No balance on record |
Spotted something wrong on this page? Report an error. We check every report against the SEC filing and list what we fix in the corrections log.